Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratios.
Introduction: Optimal sequencing of therapies is an important unresolved issue in metastatic neuroendocrine neoplasms (NEN). Progression-free survival (PFS) ratios constitute a potential method for intra-patient treatment comparisons and were used in this analysis to assess the relative treatment be...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 53; no. 1; pp. 263 - 275 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |